. 2017 Nov 13;3:2. doi: 10.1038/s41531-016-0003-z

Table 3.

Change in mean scores on the MMAS-8 between PTA and TAU groups at 16 weeks (intention-to-treat population)

Variable	Statistics/category	PTA^a	TAU^b	All
Morisky Medication Adherence Scale (MMAS-8)	n	68	90	158
	Mean (SD)	6.30 (1.52)	5.74 (1.53)	5.98 (1.55)
GLM analysis^c	Difference and 95%CI	0.39 (0.04,0.74)
	P-value	0.0304
Covariate adjusted GLM analysis^d	Difference and 95%CI	0.38 (0.03,0.73)
	P-value	0.0331

^a PTA Parkinson’s tracker app

^b Treatment as usual

^c GLM generalised linear model

^d Age, gender, number of co-morbidities, PD duration were used as covariates. Use of the ©MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research (MORISKY) 14725 NE 20th St. Bellevue, WA 98007; dmorisky@gmail.com